BioCryst Pharmaceuticals Files 2024 Annual Report
Ticker: BCRX · Form: 10-K · Filed: Feb 25, 2025 · CIK: 882796
Sentiment: neutral
Topics: annual-report, pharmaceuticals, financials
Related Tickers: BCRX
TL;DR
BCRX filed its 2024 10-K. Full financials and biz details out now.
AI Summary
BioCryst Pharmaceuticals Inc. filed its 2024 10-K on February 25, 2025, reporting on its fiscal year ending December 31, 2024. The company, headquartered in Durham, NC, operates in the biological products sector. Key financial data and operational details for the fiscal years 2024, 2023, and 2022 are presented in this comprehensive annual report.
Why It Matters
This filing provides investors and stakeholders with a detailed overview of BioCryst's financial performance, strategic initiatives, and risk factors for the past fiscal year, crucial for investment decisions.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, BioCryst faces inherent risks related to drug development, regulatory approvals, market competition, and intellectual property.
Key Numbers
- 2024 — Fiscal Year (Reporting period for the 10-K)
- 2023 — Fiscal Year (Comparative financial data)
- 2022 — Fiscal Year (Comparative financial data)
Key Players & Entities
- BIOCRYST PHARMACEUTICALS INC (company) — Filer
- DURHAM (location) — Company Headquarters City
- NC (location) — Company Headquarters State
- 2024-12-31 (date) — Fiscal Year End
- 2025-02-25 (date) — Filing Date
- 000-23186 (other) — SEC File Number
FAQ
What were BioCryst's total revenues for the fiscal year ended December 31, 2024?
The filing does not explicitly state total revenues in the provided header information. A detailed review of the financial statements within the 10-K would be required to determine this figure.
What is BioCryst's primary business segment?
BioCryst Pharmaceuticals Inc. operates in the 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)' sector, SIC code 2836.
When was BioCryst Pharmaceuticals Inc. incorporated?
The company was incorporated in Delaware (DE).
What is the ticker symbol for BioCryst Pharmaceuticals Inc.?
The ticker symbol is BCRX, and it is listed on NASDAQ.
What is the physical address of BioCryst Pharmaceuticals Inc.'s headquarters?
The company's business address is 4505 EMPEROR BOULEVARD, SUITE 200, DURHAM, NC 27703.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 25, 2025 regarding BIOCRYST PHARMACEUTICALS INC (BCRX).